| 837442 |
Brazil |
PROGRAMA NACIONAL DE CONTROLE DE QUALIDADE
PROGRAMA NACIONAL DE CONTROLE DE QUALIDADE
|
COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA
[COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA]
COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA
[COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA]
|
2022-05-30 |
|
|
| PT name |
(COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA) |
| Scheme name in national language |
(COVID-19 (SARS-CoV2) IMUNOCROMATOGRAFIA) |
|
| 699949 |
United Kingdom |
UK NEQAS for Immunology, Immunochemistry & Allergy
UK NEQAS for Immunology, Immunochemistry & Allergy
|
UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies
UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies
|
2020-08-05 |
|
|
| PT name |
(UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies) |
| Tested property |
(SARS-CoV-2 / COVID-19 Antibodies) |
|
| 690909 |
Argentina |
ILT - Interlaboratory Test S.A.
ILT - Interlaboratory Test S.A.
|
ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease)
ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease)
|
2020-06-09 |
|
|
| PT name |
(ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease)) |
| Tested property |
(Requirements, testing, marking for COVID-19) |
|
| 696054 |
Germany |
DRRR - Deutsches Referenzbüro für Ringversuche und Referenzmaterialien GmbH
DRRR - Deutsches Referenzbüro für Ringversuche und Referenzmaterialien GmbH
|
Medical face masks (EN 14683) / filtering half masks (EN 149)
[Medizinische Gesichtsmasken (EN 14683) / Filtrierende Halbmasken (EN 149)]
Medical face masks (EN 14683) / filtering half masks (EN 149)
[Medizinische Gesichtsmasken (EN 14683) / Filtrierende Halbmasken (EN 149)]
|
2021-10-29 |
|
|
| Remarks |
(PT relevant to SARS-CoV-2 virus / COVID-19) |
|
| 794057 |
Australia |
RCPAQAP
RCPAQAP
|
PHLN: SARS-CoV-2 and other coronaviruses
PHLN: SARS-CoV-2 and other coronaviruses
|
2020-10-23 |
|
|
| PT name |
(PHLN: SARS-CoV-2 and other coronaviruses) |
| Remarks |
(Department of Health funded COVID-19 program. Three rounds of this module were offered in 2020 in) (response to the COVID-19 pandemic with plans for another in 2021. This module is suitable for all) (laboratory testing platforms that are utilised in the whole genome sequencing of SARS-CoV-2.
Available) (free of charge to Australian public health laboratories that require the capability to test for SARS-CoV-2.) |
| Tested property |
(Diluted SARS-CoV-2 (inactivated)) (Diluted SARS-CoV-2 (inactivated)) |
|
| 769005 |
United Kingdom |
LGC AXIO Proficiency Testing
LGC AXIO Proficiency Testing
|
SARS-CoV-2 Proficiency Testing Scheme
SARS-CoV-2 Proficiency Testing Scheme
|
2022-05-04 |
|
|
| PT name |
(SARS-CoV-2 Proficiency Testing Scheme) |
| Test item |
(SARS-CoV-2 (Serological)- 3 x 0.75 ml samples for detection for the SARS-CoV-2 antibodies -NEW 2020) (SARS-CoV-2 (Molecular)- 2 x 1.5ml samples for SARS-CoV-2 virus -NEW 2020) (SARS-CoV-2 antigen - 3 x swab based samples (A, B, and C). Non-infectious simulated patient) (nasopharyngeal samples containing the SARS-CoV-2 nucleocapsid protein.) (SARS-CoV-2 (Molecular)- 2 x swab based samples. Non-infectious simulated nasopharyngeal samples) |
| Tested property |
(SARS-CoV-2 IgA, IgG, IgM, Total antibodies) (SARS-CoV-2 virus) (SARS-CoV-2 virus) (SARS-CoV-2 virus - The samples contain the whole genome) (SARS-CoV-2 virus - The samples contain the whole genome) |
| Testing method |
(The samples are derived from naturally occurring material collected via apheresis from patients that have recovered from COVID-19.) |
|
| 690914 |
Argentina |
ILT - Interlaboratory Test S.A.
ILT - Interlaboratory Test S.A.
|
Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112
Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112
|
2020-09-16 |
|
|
| PT name |
(Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112) |
|
| 706310 |
Portugal |
Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ
Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ
|
SARS-CoV-2, PCR
[SARS-CoV-2, PCR]
SARS-CoV-2, PCR
[SARS-CoV-2, PCR]
|
2021-03-25 |
|
|
| PT name |
(SARS-CoV-2, PCR) |
| Scheme name in national language |
(SARS-CoV-2, PCR) |
| Tested property |
(SARS-CoV-2 virus) |
|
| 824901 |
Germany |
Reference Institute for Bioanalytics
Reference Institute for Bioanalytics
|
SARS-CoV-2 Immunology
[SARS-CoV-2 Immunologie]
SARS-CoV-2 Immunology
[SARS-CoV-2 Immunologie]
|
2021-02-16 |
|
|
| PT name |
(SARS-CoV-2 Immunology) |
| Scheme name in national language |
(SARS-CoV-2 Immunologie) |
| Tested property |
(Anti-SARS-CoV-2 IgG, Anti-SARS-CoV-2 IgA) |
|
| 790376 |
Australia |
RCPAQAP
RCPAQAP
|
PoCT: COVID-19 serology (IgG/IgM)
PoCT: COVID-19 serology (IgG/IgM)
|
2020-10-26 |
|
|
| PT name |
(PoCT: COVID-19 serology (IgG/IgM)) |
| Tested property |
(COVID-19 Serology) |
|
| 907768 |
Germany |
Institut für Qualitätssicherung Lübeck (IfQ-Lübeck)
Institut für Qualitätssicherung Lübeck (IfQ-Lübeck)
|
Antibodies against SARS-CoV-2
[Antikörper gegen SARS-CoV-2]
Antibodies against SARS-CoV-2
[Antikörper gegen SARS-CoV-2]
|
2021-11-25 |
|
|
| PT name |
(Antibodies against SARS-CoV-2) |
| Scheme name in national language |
(Antikörper gegen SARS-CoV-2) |
| Tested property |
(Anti-SARS-CoV-2 (NCP) IgG) (Anti-SARS-CoV-2 (S1) IgG) |
|
| 925094 |
United Kingdom |
UK NEQAS for Microbiology
UK NEQAS for Microbiology
|
Molecular detection of SARS-CoV-2
[Molecular detection of SARS-CoV-2]
Molecular detection of SARS-CoV-2
[Molecular detection of SARS-CoV-2]
|
2022-05-13 |
|
|
| PT name |
(Molecular detection of SARS-CoV-2) |
| Scheme name in national language |
(Molecular detection of SARS-CoV-2) |
| Test item |
(/ absence of SARS-CoV-2 nucleic acid by molecular methods, genotyping of SARS-CoV-2 (if performed)) |
| Tested property |
(SARS-CoV-2 nucleic acid) |
|
| 705752 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - TLR Coronavírus (SARS-CoV2): antigen
[EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno]
Clinical PT - TLR Coronavírus (SARS-CoV2): antigen
[EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno]
|
2020-09-10 |
|
|
| PT name |
(Clinical PT - TLR Coronavírus (SARS-CoV2): antigen) |
| Scheme name in national language |
(EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno) |
| Tested property |
(Coronavírus (SARS-CoV2)) |
|
| 790103 |
Australia |
RCPAQAP
RCPAQAP
|
Coronavirus SARS CoV-2 Antibodies
Coronavirus SARS CoV-2 Antibodies
|
2020-10-27 |
|
|
| PT name |
(Coronavirus SARS CoV-2 Antibodies) |
| Tested property |
(SARS CoV-2) |
|
| 789737 |
Australia |
RCPAQAP
RCPAQAP
|
Molecular Coronavirus SARS-CoV-2
Molecular Coronavirus SARS-CoV-2
|
2020-10-28 |
|
|
| PT name |
(Molecular Coronavirus SARS-CoV-2) |
| Tested property |
(Coronavirus SARS-CoV2) |
|
| 935461 |
United Kingdom |
UK NEQAS for Microbiology
UK NEQAS for Microbiology
|
SARS-CoV-2 Point of Care
[SARS-CoV-2 Point of Care]
SARS-CoV-2 Point of Care
[SARS-CoV-2 Point of Care]
|
2022-05-13 |
|
|
| PT name |
(SARS-CoV-2 Point of Care) |
| Scheme name in national language |
(SARS-CoV-2 Point of Care) |
| Tested property |
(To determine the presence / absence of SARS-CoV-2 antigen/ nucleic acid by point of care devices such as lateral flow, LAMP and antigen test) |
|
| 705717 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Molecular Biology Coronavírus (SARS-CoV2)
[EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)]
Clinical PT - Molecular Biology Coronavírus (SARS-CoV2)
[EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)]
|
2023-01-31 |
|
|
| PT name |
(Clinical PT - Molecular Biology Coronavírus (SARS-CoV2)) |
| Scheme name in national language |
(EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)) |
| Tested property |
(Coronavírus (SARS-CoV2)) |
|
| 705734 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - Immunology Coronavírus (SARS-CoV2): Automation
[EP Clínico - Imunologia Coronavírus (SARS-CoV2): Automação ]
Clinical PT - Immunology Coronavírus (SARS-CoV2): Automation
[EP Clínico - Imunologia Coronavírus (SARS-CoV2): Automação ]
|
2020-09-10 |
|
|
| PT name |
(Clinical PT - Immunology Coronavírus (SARS-CoV2): Automation) |
| Scheme name in national language |
(EP Clínico - Imunologia Coronavírus (SARS-CoV2): Automação) |
|
| 705758 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - TLR Immunology Coronavírus (SARS-CoV2)
[EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)]
Clinical PT - TLR Immunology Coronavírus (SARS-CoV2)
[EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)]
|
2023-01-31 |
|
|
| PT name |
(Clinical PT - TLR Immunology Coronavírus (SARS-CoV2)) |
| Scheme name in national language |
(EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)) |
|
| 910247 |
Brazil |
ControlLab Controle de Qualidade para Laboratórios Ltda
ControlLab Controle de Qualidade para Laboratórios Ltda
|
Clinical PT - RLT Molecular Biology Coronavírus (SARS-CoV2)
[EP Clínico - TLR Biologia Molecular Coronavírus (SARS-CoV2) ]
Clinical PT - RLT Molecular Biology Coronavírus (SARS-CoV2)
[EP Clínico - TLR Biologia Molecular Coronavírus (SARS-CoV2) ]
|
2021-12-06 |
|
|
| PT name |
(Clinical PT - RLT Molecular Biology Coronavírus (SARS-CoV2)) |
| Scheme name in national language |
(EP Clínico - TLR Biologia Molecular Coronavírus (SARS-CoV2)) |
| Tested property |
(Coronavírus (SARS-CoV2)) |
|
